应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02410 同源康医药-B
交易中 06-02 10:28:11
8.700
-0.140
-1.58%
最高
8.990
最低
8.610
成交量
79.25万
今开
8.850
昨收
8.840
日振幅
4.30%
总市值
33.07亿
流通市值
32.66亿
总股本
3.80亿
成交额
691.34万
换手率
0.21%
流通股本
3.75亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
ASCO 2026重磅突破 | 同源康医药(02410)艾多替尼颅内客观缓解率95.5% 全面领跑EGFR肺癌脑转移一线治疗
智通财经 · 06-01 10:06
ASCO 2026重磅突破 | 同源康医药(02410)艾多替尼颅内客观缓解率95.5% 全面领跑EGFR肺癌脑转移一线治疗
同源康医药-B(02410)：艾多替尼一线治疗晚期非小细胞肺癌脑转移的关键性研究最新成果以LBA形式于2026年ASCO年会上公布
智通财经 · 05-31 18:18
同源康医药-B(02410)：艾多替尼一线治疗晚期非小细胞肺癌脑转移的关键性研究最新成果以LBA形式于2026年ASCO年会上公布
同源康医药-B拟回购最多10%股份
公告速递 · 05-22
同源康医药-B拟回购最多10%股份
创新药概念走软 药明合联(02268)领跌5.57% 机构成仍看好以创新为主医药科技主线
金吾财讯 · 05-18
创新药概念走软 药明合联(02268)领跌5.57% 机构成仍看好以创新为主医药科技主线
同源康医药-B 4月无新增发行或股份变动
公告速递 · 05-06
同源康医药-B 4月无新增发行或股份变动
格隆汇沽空预警榜 | 5月4日
格隆汇 · 05-06
格隆汇沽空预警榜 | 5月4日
同源康医药(02410)自主研发TY-3002单药展现卓越减重疗效，引领下一代口服GLP-1R小分子创新
智通财经 · 04-16
同源康医药(02410)自主研发TY-3002单药展现卓越减重疗效，引领下一代口服GLP-1R小分子创新
格隆汇沽空预警榜 | 4月14日
格隆汇 · 04-16
格隆汇沽空预警榜 | 4月14日
同源康医药-B3月股份变动月报表，股本维持稳定
公告速递 · 04-08
同源康医药-B3月股份变动月报表，股本维持稳定
同源康医药-B更新3月股份变动月报表：非上市股份转换为H股
公告速递 · 04-02
同源康医药-B更新3月股份变动月报表：非上市股份转换为H股
异动解读 | 同源康医药-B盘中大涨7.26%，因业绩发布及AACR年会展示创新药成果
异动解读 · 04-01
异动解读 | 同源康医药-B盘中大涨7.26%，因业绩发布及AACR年会展示创新药成果
港股异动 | 同源康医药-B(02410)涨超7% 年度研发成本约2.44亿元 将于AACR年会展示五项创新药研究成果
智通财经 · 04-01
港股异动 | 同源康医药-B(02410)涨超7% 年度研发成本约2.44亿元 将于AACR年会展示五项创新药研究成果
同源康医药-B(02410)发布年度业绩 研发成本约2.44亿元 同比增加3.7%
智通财经 · 03-30
同源康医药-B(02410)发布年度业绩 研发成本约2.44亿元 同比增加3.7%
同源康医药-B(02410)将于2026年AACR年会上展示五个创新药项目的研究成果
智通财经 · 03-25
同源康医药-B(02410)将于2026年AACR年会上展示五个创新药项目的研究成果
同源康医药-B03月11日主力净流出24.9万元 散户资金买入
市场透视 · 03-11
同源康医药-B03月11日主力净流出24.9万元 散户资金买入
每日卖空追踪 | 同源康医药-B 03月09日卖空量成交1.4万股，卖空比例为0.63%
市场透视 · 03-09
每日卖空追踪 | 同源康医药-B 03月09日卖空量成交1.4万股，卖空比例为0.63%
同源康医药-B03月06日获主力加仓207.5万元
市场透视 · 03-06
同源康医药-B03月06日获主力加仓207.5万元
港股异动 | 同源康医药-B(02410)涨超5% 公司完成H股全流通 艾多替尼上市申请获正式受理并纳入优先审评
智通财经网 · 03-06
港股异动 | 同源康医药-B(02410)涨超5% 公司完成H股全流通 艾多替尼上市申请获正式受理并纳入优先审评
同源康医药-B（02410）更新翌日披露报表，持股变动1.23%
公告速递 · 03-04
同源康医药-B（02410）更新翌日披露报表，持股变动1.23%
同源康医药-B（02410）2026年2月无新增发行或股份变动
公告速递 · 03-04
同源康医药-B（02410）2026年2月无新增发行或股份变动
加载更多
公司概况
公司名称：
同源康医药-B
所属市场：
SEHK
上市日期：
--
主营业务：
浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发，其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI，对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂，用于治疗实体瘤。
发行价格：
--
{"stockData":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药-B","latestPrice":8.7,"timestamp":1780367270368,"preClose":8.84,"halted":0,"volume":792500,"delay":0,"changeRate":-0.015837104072398255,"floatShares":375457818,"shares":380065818,"eps":-0.8,"marketStatus":"交易中","change":-0.14,"latestTime":"06-02 10:28:11","open":8.85,"high":8.99,"low":8.61,"amount":6913420,"amplitude":0.042986,"askPrice":8.71,"askSize":5000,"bidPrice":8.67,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":-0.890654,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1780372800000},"marketStatusCode":2,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":8.84,"openAndCloseTimeList":[[1780363800000,1780372800000],[1780376400000,1780387200000]],"volumeRatio":0.831007,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02410","defaultTab":"news","newsList":[{"id":"2640982166","title":"ASCO 2026重磅突破 | 同源康医药(02410)艾多替尼颅内客观缓解率95.5% 全面领跑EGFR肺癌脑转移一线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2640982166","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640982166?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:06","pubTimestamp":1780279582,"startTime":"0","endTime":"0","summary":"港股创新药企同源康医药自主研发的新一代EGFR-TKI创新药甲磺酸艾多替尼片，用于EGFR突变非小细胞肺癌脑转移患者一线治疗的关键II期ESAONA研究期中分析结果，以最新突破性摘要口头报告形式重磅发布。商业化进程加速落地，有望重塑肺癌脑转移治疗格局依托ESAONA研究的突破性阳性数据，艾多替尼已展现出疗效更优、安全性可控、差异化优势显著的核心产品力，有望成为EGFR突变肺癌脑转移患者的一线优选全新方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","BK1161","159938","09939","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639600214","title":"同源康医药-B(02410)：艾多替尼一线治疗晚期非小细胞肺癌脑转移的关键性研究最新成果以LBA形式于2026年ASCO年会上公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2639600214","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639600214?lang=zh_cn&edition=full","pubTime":"2026-05-31 18:18","pubTimestamp":1780222714,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，本公司自主研发的甲磺酸艾多替尼片 对比奥希替尼一线治疗表皮生长因子受体突变非小细胞肺癌 脑转移患者关键II期ESAONA研究的期中分析结果，已于2026年美国临床肿瘤学会年会上以最新突破性摘要“LBA”口头报告形式公布。ESAONA研究是一项开放标签、多中心、随机对照的关键II期临床研究，旨在评估艾多替尼对比奥希替尼一线治疗EGFR经典突变NSCLC脑转移患者的疗效和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","BK1515","159938","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145602800","title":"同源康医药-B拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1145602800","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145602800?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:36","pubTimestamp":1779438967,"startTime":"0","endTime":"0","summary":"同源康医药-B近日发布公告称，公司董事会拟于2026年6月23日召开年度股东大会，审议并授权董事会于相关期间内回购不超过已发行H股总数10%的股份。根据公告，截至最后可行日期，公司已发行H股总数约为380,065,818股，若授权获批，最多可回购38,006,581股。按照议程安排，该回购计划仍需获得本次年度股东大会通过。据公告介绍，公司同期将于2026年6月17日至6月23日暂时关闭H股股东名册，所有在此期间登记在册的股东均可出席大会并表决。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"同源康医药-B拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636048086","title":"创新药概念走软 药明合联(02268)领跌5.57% 机构成仍看好以创新为主医药科技主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2636048086","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636048086?lang=zh_cn&edition=full","pubTime":"2026-05-18 10:09","pubTimestamp":1779070152,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念整体走软，截至发稿，药明合联 跌5.57%，亚盛医药-B跌5.50%，四环医药跌4.55%，康方生物跌4.49%，歌礼制药-B跌4.36%，同源康医药-B跌4.31%，康诺亚-B跌4.24%，荣昌生物跌4.14%。展望2026年，该机构继续看好以创新为主的医药科技主线，重点关注创新药、脑机接口、AI医疗、手术机器人等，同时建议布局2026年行业有望迎来反转的老龄化及院外消费，关注估值较低的麻药、血制品、中药等。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981521","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","09995","BK1574","LU2476274720.SGD","LU1961090484.USD","LU2778985437.USD","09926","LU0348827113.USD","IE00B543WZ88.USD","LU2476274308.USD","LU0348735423.USD","00460","LU0417516902.SGD","02268","BK1583","LU1720050803.USD","09939","LU0561508036.HKD","02162","LU1794554557.SGD","LU0348766576.USD","LU1969619763.USD","02410","BK1141","BK1191","LU0417516571.SGD","LU0634319403.HKD","LU2399975544.HKD","BK1587","159938","LU2328871848.SGD","IE00BPRC5H50.USD","LU0540923850.HKD","LU2488822045.USD","01672","06855","LU0348783233.USD","LU0348825331.USD","IE00B5MMRT66.SGD","06978","BK1600","LU0348767384.USD","SG9999014674.SGD","LU0348784397.USD","BK1515","159992","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126163298","title":"同源康医药-B 4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1126163298","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126163298?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:33","pubTimestamp":1778060025,"startTime":"0","endTime":"0","summary":"2026年5月6日，浙江同源康医药股份有限公司公布截至2026年4月30日的证券变动月报。公告显示，公司法定/注册股本为人民币380,065,818元，对应已发行股份总数380,065,818股，库存股份数量为0。报告期内，公司未发生新增发行、购回、注销或库存股变动，股本维持稳定。公司同时在公告中确认符合香港联合交易所有限公司相关上市规则下对公众持股量的要求。公司表示将继续遵守香港联交所《上市规则》及相关法律法规的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925374","title":"格隆汇沽空预警榜 | 5月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925374","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633925374?lang=zh_cn&edition=full","pubTime":"2026-05-06 02:15","pubTimestamp":1778004900,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为21.54%，过去两个月大市日均沽空比例为20.42%。其中，PP中新经济-U、X南方中五百、吉利汽车-R沽空比率排名前三位，分别为100.00%、100.00%、100.00%。小米集团-W、盈富基金、阿里巴巴-W的沽空金额排名前三位，分别为30.98亿、28.52亿、15.97亿。IFBH、中国中免、上海医药的偏离值排名前三位，分别为9.28、9.09、6.18。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/06021557004862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0516423091.SGD","HK0000286598.CNH","LU1688375341.USD","SGXZ90724238.SGD","LU0320764243.SGD","LU1064130708.USD","LU0054237671.USD","LU0210533765.USD","SGXZ81514606.USD","LU0823040885.USD","LU1226288170.HKD","LU2097828474.EUR","TCEHY","IE0034224299.USD","LU2106854487.HKD","LU0516422440.USD","LU1961090484.USD","LU1568876251.USD","LU1044876610.USD","LU0543330483.HKD","HK0000352382.USD","LU2097829019.USD","BK1141","LU0163747925.USD","LU1366334578.USD","LU0463099449.HKD","LU0175139822.USD","LU0229945570.USD","LU0164865239.USD","LU2125910500.SGD","LU0128522744.USD","LU2008162690.USD","LU2087589342.USD","BK1588","LU2357305700.SGD","LU1226287792.SGD","LU0348783662.USD","LU2279701549.SGD","LU0868486357.SGD","LU2498475776.HKD","LU0531971595.HKD","LU0630378692.HKD","LU1044875133.USD","SG9999001093.SGD","LU0588546209.SGD","HK0000914686.HKD","LU0738912210.USD","LU1366334651.USD","LU0516423174.USD","LU0501845795.SGD","HYDD.SI","BK1608","LU0823041008.USD","IE00B0169L03.USD","SG9999002562.SGD","LU0572944931.SGD","LU0210527791.USD","BK1193","LU0261950983.USD","LU2362540622.SGD","LU1981816686.USD","LU1785774172.SGD","LU0192582467.USD","LU1328277881.USD","LU0047713382.USD","LU0345776255.USD","LU2488822045.USD","SG9999003461.SGD","LU0259732245.USD","SG9999002828.SGD","LU1196710195.USD","LU0456842615.SGD","LU1242518857.USD","LU0577902371.SGD","LU0633140560.USD","LU1226288253.USD","LU0251144936.SGD","BK1564","LU0784639295.USD","BK1119","LU1152091168.USD","LU2125910849.SGD","LU2039709279.SGD","LU0633140727.USD","LU0345775950.USD","LU1102505762.USD","BK1197","02410","IE00B031HY20.USD","LU1102505929.USD","SG9999000327.SGD","00700","LU0786609619.USD","81810","LU0315178854.USD","LU0577902611.USD","SG9999018865.SGD","SGXZ62798434.SGD","LU1642822792.SGD","LU0348783233.USD","LU0516422952.EUR","LU0985320562.USD","LU1201861165.SGD","LU0235996351.USD","03958","LU0244354667.USD","IE00B8HQ1Z84.USD","IE00B97KM107.HKD","IE0032431581.USD","IE0008369823.USD","LU0441854154.USD","SG9999001903.USD","LU0880133367.SGD","BK1609","LU0084288322.USD","LU1804176565.USD","LU1105468828.SGD","LU1548497426.USD","LU0149534421.HKD","LU1880383440.USD","LU0348816934.USD","SG9999002950.SGD","BK1583","LU0541501648.USD","LU0469268626.HKD","LU0203345920.USD","BK1540","LU0488056044.USD","LU0650527681.SGD","BK1586","IE0003851619.USD","02587","LU0289961442.SGD","LU1196710864.SGD","HBBD.SI","LU0898667661.SGD","LU1720050803.USD","IE0008368742.USD","LU1960683339.HKD","LU0505663152.USD","LU0326950275.SGD","06603","LU0828238088.HKD","LU0634319403.HKD","02431","LU1807302812.USD","IE0032834883.USD","LU1044874839.SGD","LU0107464264.USD","HTCD.SI","BK1501","LU0289739343.SGD","LU0708995153.HKD","LU1951186391.HKD","LU0048580855.USD","02800","LU0823413660.USD","BK1582","LU0630378429.USD","LU0359202008.SGD","LU2294711713.HKD","BK1144","LU0819121731.USD","LU0979878070.USD","LU0873338254.USD","LU0791590937.USD","01951","MIUmain","SG9999001846.SGD","LU0511384066.AUD","LU1224444064.USD","LU1224709979.USD","LU0130103400.USD","LU0608807946.USD","LU1115378108.SGD","LU0414403682.SGD","LU0214875030.USD","LU1880398554.USD","LU0293314216.USD","IE00B0169N27.USD","LU2317271919.USD","LU2362541513.USD","LU1244550577.SGD","LU1725190679.HKD","LU0348766576.USD","IE00B031HW06.USD","LU2226246903.HKD","09988","BK1516","BK1531","LU0127658192.USD","BK1161","LU0348788117.USD","LU1211504680.USD","02338","LU1244550494.USD","LU0328353924.USD","BK1615","LU0320764755.SGD","LU0029874905.USD","BK1237","BK1575","SG9999002463.SGD","IE0001KFT4U8.USD","LU0449509016.USD","LU0700851271.USD","LU0594300179.USD","LU2177674079.SGD","SG9999004220.SGD","LU0117844026.USD","LU0737861699.HKD","LU1831875114.USD","HK0000320223.HKD","LU0531970944.HKD","BK1224","LU0269904917.USD","IE00B067MR52.USD","601633","BK1249","HXXD.SI","SG9999014674.SGD","LU2251237488.HKD","LU0456846285.SGD","LU0456827905.SGD","LU0862451837.USD","09159","IE00BZ08YS42.EUR","LU0067412154.USD","LU0128522157.USD","LU1720051108.HKD","LU2152927971.USD","LU2237443465.HKD","LU0140636845.USD","LU0762542818.HKD","LU0039217434.USD","BK1594","LU1282651048.USD","LU1316542783.SGD","LU1303224171.USD","LU0348767384.USD","LU2133065610.SGD","LU1675838814.USD","LU1251922891.USD","SGXZ51526630.SGD","LU0577902454.USD","LU0823414551.USD","LU0061477393.USD","LU0572940350.SGD","LU0683595622.HKD","IE00BD6J9T35.USD","LU0577902298.EUR","LU1439102457.SGD","LU0541502299.USD","LU2476274308.USD","LU0359201612.USD","GB00BDT5M118.USD","LU0173614495.USD","LU0605514214.HKD","LU2045819591.USD","BK1171","IE00B543WZ88.USD","IE00B0JY6N72.USD","LU0043850808.USD","LU0164880469.USD","01211","LU1323998911.USD","IE0008368411.USD","HK0000306685.HKD","LU0588545904.SGD","BK1526","02607","LU2257852520.SGD","LU0708995583.HKD","LU0651946864.USD","LU1023057109.AUD","IE00BMPRXN33.USD","LU1861214812.USD","SG9999001226.SGD","81211","HK0000151867.HKD","LU1064131003.USD","IE00BQXX3F31.USD","LU0211331839.USD","LU1993786604.SGD","LU1328615791.USD","LU0823414478.USD","LU0831093199.SGD","SG9999000459.SGD","83189","LU0054450605.USD","LU0577902538.SGD","LU1515016050.SGD","BK1142","LU0197773673.USD","LU0611395673.USD","LU0345769128.USD","LU0449515922.USD","LU0540923850.HKD","LU1734074674.USD","LU1917777945.USD","SGXZ31699556.SGD","LU0106959298.USD","LU1282651121.HKD","83111","LU0188438112.USD","BK1509","LU0918141887.USD","LU0289960550.SGD","HSI","SG9999015986.USD","LU1868837565.USD","LU0320764599.SGD","01880","SG9999014898.SGD","LU1814569148.SGD","HK0001040168.HKD","LU1504937902.USD","LU0878005551.USD","LU1733274473.HKD","LU2778985437.USD","IE0003895053.USD","LU0052750758.USD","LU0823413587.USD","LU1880398471.USD","HSTECH","BK1095","SGXZ99366536.SGD","LU0865486749.SGD","SG9999000418.SGD","LU1769817179.HKD","LU1770034418.SGD","09173","LU0264606111.USD","LU0648948544.HKD","LU0314109678.HKD","LU1282648689.USD","LU0096374516.USD","LU1188198961.HKD","LU0543330566.HKD","LU1956131251.USD","IE0003795394.USD","LU0455707207.USD","LU0417516571.SGD","SG9999015952.SGD","LU1720051017.SGD","LU0509642566.USD","LU2399975544.HKD","XIACY","IE00BGV7N243.SGD","LU2249611893.SGD","IE00B031J352.USD","BK1502","LU1048588211.SGD","LU0345769631.USD","LU1048484197.HKD","LU2265009873.SGD","ALBmain","LU2237443382.USD","LU0210526637.USD","LU0588545490.SGD","LU0261947096.USD","LU1813983027.USD","LU2097828805.USD","LU0348814723.USD","LU0048388663.USD","LU0672654166.SGD","LU0231483743.USD","HK0000165453.HKD","LU0348825331.USD","SG9999001069.SGD","LU2251237306.USD","LU1048596156.SGD","LU1226288097.SGD","LU0516422366.SGD","LU2294711473.HKD","LU0228367735.SGD","LU0499858602.USD","09992","LU0791591158.USD","LU1883866441.USD","LU2148510915.USD","LU0823038988.USD","IE00BPRC5H50.USD","LU1861219969.SGD","LU0871576103.HKD","LU0348735423.USD","LU0828237510.HKD","LU0080751232.USD","LU0431992006.USD","LU0762541174.USD","LU0886674414.USD","LU1226287529.USD","LU3063872942.SGD","89988","LU1655091459.SGD","LU0165289439.USD","BABA","LU0329678170.USD","IE00BZ08YR35.GBP","SG9999014880.SGD","LU0197773160.USD","BYDDY","LU0651947912.USD","LU0130518102.USD","LU0327786744.USD","SG9999006597.SGD","SG9999013353.USD","LU1008478684.HKD","BK1618","HK0000352291.HKD","LU0106252389.USD","BK1517","LU0828237940.HKD","LU0370786039.SGD","SG9999017495.SGD","LU0287142896.SGD","TCHmain","LU1481107354.HKD","601607","601888","SG9999014914.USD","SG9999006514.SGD","LU0823426308.USD","LU1691799644.USD","LU2506951792.HKD","LU0011963245.USD","SG9999001689.USD","LU0029875118.USD","LU0648000940.SGD","03137","LU0164872284.USD","GWLLY","LU0607220059.USD","LU0132412106.USD","LU1974910355.USD","LU1868838027.USD","LU0642271901.SGD","IE00BMPRXR70.SGD","HK0000306701.USD","LU0762540952.USD","LU0196878994.USD","LU0051755006.USD","LU2237443549.SGD","03759","LU0315179316.USD","688236","LU0918141705.HKD","LU0211977185.USD","LU2097828631.EUR","BK1610","LU1244550221.USD","LU0862451753.SGD","LU2237443978.SGD","LU2237443895.HKD","LU0737861772.HKD","LU2293587155.HKD","IE00BQXX3D17.EUR","BK1597","LU1868837722.USD","LU2362541273.HKD","IE00BZ08YT58.USD","LU1226287875.USD","LU2051468812.USD","BK1522","LU0972618739.USD","HK0000914660.USD","LU0384037296.USD","HK0001040143.USD","LU1046422090.SGD","09803","82333","SGXZ86797644.SGD","LU1051768304.USD","LU1439103000.SGD","LU0326948709.USD","LU1719994722.HKD","LU0348827113.USD","SG9999011746.SGD","LU0348723411.USD","LU0675040207.SGD","IE00B3M56506.USD","03005","LU2153592121.USD","LU0417516902.SGD","BK1589","LU0572939691.SGD","BK1607","IE0009570106.USD","LU1051769294.HKD","LU0149721374.USD","LU0181495838.USD","LU0588545730.USD","LU2360107325.USD","BK1100","LU0348805143.USD","BK1584","LU1152091754.HKD","LU2476274720.SGD","LU0143863784.USD","IE00B8L5B284.USD","LU1235295612.USD","LU1629966141.USD","LU0878004406.USD","LU1282649141.HKD","LU0228659784.USD","BK1585","LU0593848301.USD","LU0329678337.USD","HK0000107257.USD","LU2023250504.SGD","LU0072913022.USD","LU0823039010.USD","SG9999014906.USD","LU0819123356.HKD","LU1769817096.USD","HK0000320264.USD","LU2357125470.USD","SG9999015945.SGD","LU0882747503.HKD","LU0254981946.USD","LU0594300419.USD","LU0106259558.USD","IE00BQXX3C00.GBP","LU0117841782.USD","BK1147","LU0589944569.HKD","BK1219","LU0797268264.HKD","LU0477156797.USD","LU1282649810.SGD","LU1810669033.SGD","PMRTY","LU0890818403.SGD","LU0823397103.USD","LU2237443622.USD","002594","LU0072462343.USD","LU0143863198.USD","LU0823397285.USD","IE00B5MMRT66.SGD","LU0049853897.USD","LU0499858438.USD","LU1196710351.USD","01810","LU2097828714.EUR","SG9999018857.SGD","IE00BF5LJ272.USD","SG9999015978.USD","LU2247934214.USD","BK1591","LU0502904849.HKD","LU1880383366.USD","LU2449936058.SGD","03033","300759","LU0608807433.USD","BK1576","LU0359201885.HKD","LU0396098781.USD","LU0561508036.HKD","LU2543165471.USD","LU0048597586.USD","LU0169518387.USD","LU0856984785.SGD","BK1523","LU1568876335.HKD","LU0348784397.USD","80175","000338","LU0307460666.USD","01858","IE0031814852.USD","LU0821914370.USD","LU0049112450.USD","LU1718418525.SGD","LU1794554557.SGD","LU2348774022.SGD","IE0008368304.USD","SHPMY","LU1242518931.SGD","SG9999007991.SGD","LU0640798160.USD","LU1733274390.USD","SG9999001051.SGD","LU1808992512.USD","IE00B29SXG58.USD","LU0831103253.SGD","LU0417516738.SGD","BK1539","LU0823426480.USD","LU2242644610.SGD","BK1521","LU1282649067.USD","LU1770036033.HKD","LU0203347892.USD","LU0070217475.USD","LU2097828557.USD","LU2462611646.USD","BK1506"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2627829301","title":"同源康医药(02410)自主研发TY-3002单药展现卓越减重疗效，引领下一代口服GLP-1R小分子创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2627829301","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627829301?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:07","pubTimestamp":1776330475,"startTime":"0","endTime":"0","summary":"近日，同源康医药宣布正式提名其自主研发的下一代口服小分子GLP-1R激动剂TY-3002为临床前候选化合物。在反映临床潜力的hGLP-1R饮食诱导肥胖小鼠头对头试验中，TY-3002展现出了优越的减重效果。治疗21天后，TY-3002组小鼠的体重极显著地下降了-31.51%，而同等剂量的Orforglipron组降幅为-22.82%。新一代GLP-1R小分子TY-3002的提名，充分彰显了同源康医药领先的分子设计能力，也为全球下一代口服减重药物领域开启了新的竞争格局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK4590","BK1161","TY","BK1515","BK1574","09939","GLP","BK4144","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627083232","title":"格隆汇沽空预警榜 | 4月14日","url":"https://stock-news.laohu8.com/highlight/detail?id=2627083232","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627083232?lang=zh_cn&edition=full","pubTime":"2026-04-16 02:15","pubTimestamp":1776276900,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为18.53%，过去两个月大市日均沽空比例为21.09%。其中，京东健康-R、长城汽车-R、价值黄金-U沽空比率排名前三位，分别为100.00%、100.00%、100.00%。盈富基金、南方恒生科技、恒生中国企业的沽空金额排名前三位，分别为48.57亿、26.63亿、16.63亿。涂鸦智能-W、中国飞机租赁、一脉阳光的偏离值排名前三位，分别为5.44、5.12、4.19。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/04/16021556767168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0348827113.USD","LU2097829019.USD","LU2362540622.SGD","IE00BZ08YT58.USD","LU3063872942.SGD","HSCEI","BYDDY","LU0259732245.USD","LU1568876251.USD","BK1152","BK1230","LU0791590937.USD","BK1522","BK4526","LU1064131003.USD","LU1102505929.USD","LU2177674079.SGD","82823","BK1501","LU0345769631.USD","LU2265009873.SGD","LU0823426480.USD","LU0531970944.HKD","LU0396098781.USD","LU1880383366.USD","BK1516","LU0449515922.USD","LU0169518387.USD","LU0132412106.USD","LU1439102457.SGD","06618","LU0128522157.USD","LU0326948709.USD","SG9999000459.SGD","LU0823038988.USD","LU0737861699.HKD","SG9999001069.SGD","LU2045819591.USD","IE00B5MMRT66.SGD","LU2293587155.HKD","LU0823040885.USD","IE00BZ08YS42.EUR","BK1224","SG9999001689.USD","LU1868837722.USD","LU0762541174.USD","LU0738912210.USD","SG9999013353.USD","BK1584","LU0293314216.USD","LU0348784397.USD","MCHmain","LU0862451837.USD","LU0972618739.USD","IE00BGV7N243.SGD","LU0630378429.USD","IE0001KFT4U8.USD","LU1044875133.USD","SG9999006597.SGD","LU1226288253.USD","LU2242644610.SGD","NUGT","LU0737861772.HKD","LU0235996351.USD","LU1675838814.USD","BK1235","BK1618","LU0348783233.USD","LU0511384066.AUD","86618","LU1282648689.USD","BK1233","LU0607220059.USD","BK1610","MIUmain","LU1102505762.USD","LU0540923850.HKD","IE00B29SXG58.USD","HK0000352382.USD","LU0588545490.SGD","BK1129","LU0823414551.USD","LU0348805143.USD","LU0188438112.USD","LU2237443382.USD","BK1589","LU0856984785.SGD","LU0029874905.USD","81810","LU2476274720.SGD","LU0070217475.USD","LU0823426308.USD","BK1571","LU1366334578.USD","SGXZ62798434.SGD","BK1193","GLD","LU0505663152.USD","LU0164872284.USD","LU1718418525.SGD","09696","LU0979878070.USD","LU2226246903.HKD","LU0054450605.USD","HK0000320223.HKD","LU0314109678.HKD","LU1226288170.HKD","LU0210533765.USD","LU0642271901.SGD","BK1588","BK1539","LU1794554557.SGD","BK1161","LU2097828474.EUR","LU0348825331.USD","LU0648948544.HKD","LU1691799644.USD","BK1109","IE00BQXX3D17.EUR","LU0049853897.USD","LU0320764755.SGD","LU0823039010.USD","TCEHY","LU1720050803.USD","IE0003895053.USD","LU0605514214.HKD","LU0067412154.USD","LU0143863198.USD","LU1769817179.HKD","SGHIY","IE0009570106.USD","LU0328353924.USD","LU0588545730.USD","LU0823041008.USD","LU0117841782.USD","LU1720051108.HKD","LU1152091168.USD","IE00BQXX3C00.GBP","LU0561508036.HKD","LU1051769294.HKD","BK1506","LU0203347892.USD","SG9999006514.SGD","LU0329678337.USD","SG9999001846.SGD","HK0001040143.USD","HK0001040168.HKD","LU0469268626.HKD","03135","LU0823397285.USD","LU1328615791.USD","LU1051768304.USD","LU0048580855.USD","BK1142","BK1609","LU0675040207.SGD","02016","LU0608807433.USD","LU0029875118.USD","LU0786609619.USD","LU1188198961.HKD","LU1201861165.SGD","LU0128522744.USD","HK0000320264.USD","LU1196710864.SGD","HK0000914686.HKD","LU2087589342.USD","LU0762540952.USD","LU0634319403.HKD","LU0985320562.USD","GWLLY","LU0117844026.USD","LU0871576103.HKD","IE0032834883.USD","LU0130518102.USD","LU2237443622.USD","LU0163747925.USD","LU0531971595.HKD","LU1883866441.USD","HMTD.SI","LU1251922891.USD","BK1591","LU1733274473.HKD","LU0149721374.USD","LU2348774022.SGD","LU0348783662.USD","LU0516423091.SGD","LU2106854487.HKD","LU0828237940.HKD","LU2294711713.HKD","LU0589944569.HKD","LU2125910849.SGD","LU0127658192.USD","03866","LU2778985437.USD","LU0011963245.USD","BK1124","LU0228367735.SGD","SG9999014674.SGD","LU0359202008.SGD","LU1868837565.USD","BK1247","SG9999007991.SGD","LU0327786744.USD","SGXZ51526630.SGD","LU0823414478.USD","LU0143863784.USD","LU0672654166.SGD","SGXZ99366536.SGD","BK1231","LU0516422366.SGD","LU0456842615.SGD","BK4023","LU0791591158.USD","LU0823397103.USD","SG9999015952.SGD","LU0880133367.SGD","SGXZ31699556.SGD","LU1568876335.HKD","LU0359201612.USD","LU0882747503.HKD","LU1366334651.USD","IE00B0JY6N72.USD","IE0008368304.USD","03033","HK0000151867.HKD","LU0633140560.USD","LU1861219969.SGD","LU0072913022.USD","LU1770034418.SGD","LU2148510915.USD","LU1813983027.USD","BK1095","LU0061477393.USD","BK1560","LU0210527791.USD","LU0611395673.USD","LU0080751232.USD","LU1044876610.USD","02800","01810","LU1439103000.SGD","SG9999002562.SGD","LU0431992006.USD","LU1105468828.SGD","LU0348735423.USD","LU0593848301.USD","IE00B543WZ88.USD","LU0651946864.USD","LU2360107325.USD","SG9999002463.SGD","SGXZ81514606.USD","LU0106252389.USD","LU1981816686.USD","LU1868838027.USD","SG9999018857.SGD","LU0501845795.SGD","09988","LU0211977185.USD","LU1023057109.AUD","LU0650527681.SGD","LU0499858602.USD","LU0543330566.HKD","83081","80020","00363","LU2039709279.SGD","SG9999001903.USD","LU2125910500.SGD","LU0630378692.HKD","SG9999015945.SGD","LU0648000940.SGD","601916","LU1048588211.SGD","LU0417516738.SGD","BK1249","LU1785774172.SGD","300750","LU0640798160.USD","LU1974910355.USD","LU1303224171.USD","BK1502","LU1769817096.USD","LU1725190679.HKD","HXXD.SI","IE0034224299.USD","IE0008368411.USD","LU0898667661.SGD","LU2247934214.USD","IE00BMPRXR70.SGD","LU2317271919.USD","LU1048596156.SGD","LU0821914370.USD","IE00B3M56506.USD","LU0130103400.USD","LU0329678170.USD","LU2251237488.HKD","00371","LU2237443895.HKD","BK1523","LU1152091754.HKD","LU2357305700.SGD","LU0320764599.SGD","601633","SG9999000327.SGD","LU2476274308.USD","LU0051755006.USD","LU0823413660.USD","HK0000165453.HKD","LU1115378108.SGD","01848","LU1211504680.USD","LU1196710351.USD","LU0463099449.HKD","LU2237443465.HKD","SG9999015978.USD","LU0608807946.USD","LU0878004406.USD","BK1604","LU1719994722.HKD","LU0488056044.USD","LU0348816934.USD","LU0594300419.USD","LU0173614495.USD","ALBmain","LU1733274390.USD","LU0289960550.SGD","09081","LU1880398471.USD","IE00BPRC5H50.USD","LU1226287792.SGD","LU0289961442.SGD","02410","LU1282651121.HKD","89988","LU2249611893.SGD","LU2449936058.SGD","IE0032431581.USD","LU0192582467.USD","LU0289739343.SGD","SG9999003461.SGD","08030","LU1688375341.USD","LU0577902538.SGD","BK1509","LU0516422440.USD","HK0000306701.USD","LU1814569148.SGD","LU0577902298.EUR","LU2237443549.SGD","BK1583","LU0370786039.SGD","LU0269904917.USD","01211","LU0890818403.SGD","LU0039217434.USD","LU0047713382.USD","LU0251144936.SGD","IE00B8HQ1Z84.USD","LU0320764243.SGD","HK0000306685.HKD","LU2152927971.USD","02522","SGCmain","TCHmain","LU1048484197.HKD","LU1504937902.USD","03443","SG9999001093.SGD","LU1242518857.USD","LU2357125470.USD","LU0054237671.USD","LU1242518931.SGD","LU0348766576.USD","BK1540","SG9999014880.SGD","518880","LU0541501648.USD","LU1917777945.USD","LU2237443978.SGD","LU0708995583.HKD","LU1323998911.USD","LU0264606111.USD","IE00B0169L03.USD","SG9999000418.SGD","LU1515016050.SGD","LU1807302812.USD","LU0287142896.SGD","LU0831093199.SGD","LU1993786604.SGD","LU0831103253.SGD","SG9999004220.SGD","IE00BMPRXN33.USD","IE00BZ08YR35.GBP","LU0229945570.USD","LU0197773673.USD","IE00BQXX3F31.USD","LU2506951792.HKD","LU1046422090.SGD","LU1282649810.SGD","LU2097828805.USD","HSTECH","LU1064130708.USD","LU0107464264.USD","LU2097828714.EUR","159934","LU1328277881.USD","LU0261950983.USD","LU0048597586.USD","LU0181495838.USD","LU0633140727.USD","600941","LU0797268264.HKD","LU1734074674.USD","LU2251237306.USD","MPNGY","XIACY","LU1861214812.USD","SG9999002950.SGD","IE00BF5LJ272.USD","02333","002466","BK1526","LU0096374516.USD","LU0211331839.USD","LU1235295612.USD","LU1629966141.USD","IE00B067MR52.USD","LU2153592121.USD","LU0315179316.USD","HBBD.SI","LU0348814723.USD","LU1880383440.USD","002594","PMRTY","80941","LU1226287875.USD","LU0348788117.USD","LU0700851271.USD","LU0345775950.USD","LU0052750758.USD","METmain","LU2543165471.USD","LU0819123356.HKD","LU0214875030.USD","SGXZ86797644.SGD","LU2488822045.USD","LU0072462343.USD","IE0031814852.USD","LU2051468812.USD","LU0417516902.SGD","LU1282649067.USD","LU2362541273.HKD","LU1224444064.USD","LU0516422952.EUR","SG9999001051.SGD","LU0541502299.USD","LU0577902454.USD","BK1116","LU0244354667.USD","LU0414403682.SGD","LU0594300179.USD","LU1960683339.HKD","LU0477156797.USD","SG9999014898.SGD","BK1500","LU2362541513.USD","LU0210526637.USD","LU0307460666.USD","LU0455707207.USD","BK1552","LU0683595622.HKD","LU0918141887.USD","LU0543330483.HKD","BK4505","IE0008369823.USD","LU0577902371.SGD","LU0417516571.SGD","002948","82333","LU2097828557.USD","LU0149534421.HKD","03750","LU2498475776.HKD","00700","GB00BDT5M118.USD","IE00B97KM107.HKD","BK1188","LU1226288097.SGD","LU0261947096.USD","SG9999014914.USD","LU2399975544.HKD","SGUmain","LU2097828631.EUR","IE0003851619.USD","LU0348723411.USD","LU2008162690.USD","LU0708995153.HKD","LU0509642566.USD","SG9999002828.SGD","LU0865486749.SGD","SG9999018865.SGD","LU0456827905.SGD","LU0164880469.USD","BK1219","LU1880398554.USD","LU0106259558.USD","LU1044874839.SGD","IE00B8L5B284.USD","LU1196710195.USD","LU1831875114.USD","LU0918141705.HKD","LU0572939691.SGD","03690","LU0254981946.USD","BK1521","02391","LU2257852520.SGD","HSI","LU0228659784.USD","LU0823413587.USD","LU0164865239.USD","LU2023250504.SGD","HYDD.SI","LU0516423174.USD","LU1956131251.USD","LU1481107354.HKD","BK1607","LU1226287529.USD","HK0000107257.USD","LU0502904849.HKD","LU0828238088.HKD","LU0828237510.HKD","BK1608","LU1808992512.USD","LU0196878994.USD","LU0345769128.USD","TUYA","LU0345776255.USD","LU1642822792.SGD","SG9999001226.SGD","LU0203345920.USD","SG9999017495.SGD","LU0043850808.USD","LU0588546209.SGD","LU0140636845.USD","BK1531","BK4509","SG9999014906.USD","LU0165289439.USD","LU1008478684.HKD","LU2294711473.HKD","LU0784639295.USD","LU1282651048.USD","IE00BD6J9T35.USD","LU0084288322.USD","BK1594","BK1515","BK1582","LU1282649141.HKD","LU0326950275.SGD","09992","BK1575","IE00B0169N27.USD","LU1655091459.SGD","LU0873338254.USD","BABA","IE0008368742.USD","BK1194","HTCD.SI","LU0231483743.USD","LU1224709979.USD","LU0048388663.USD","LU0456846285.SGD","LU0359201885.HKD","LU1770036033.HKD","LU0449509016.USD","IE0003795394.USD","LU0572944931.SGD","LU1316542783.SGD","LU0878005551.USD","BK1503","LU0197773160.USD","LU0384037296.USD","BK1517","LU1548497426.USD","81211","LU1720051017.SGD","BK1119","LU2279701549.SGD","HK0000286598.CNH","LU0499858438.USD","HK0000352291.HKD","LU0819121731.USD","LU0862451753.SGD","LU2462611646.USD","LU0175139822.USD","LU1961090484.USD","SG9999015986.USD","LU0588545904.SGD","IE00B031J352.USD","LU1810669033.SGD","BK1586","02828","LU0441854154.USD","SGXZ90724238.SGD","LU0762542818.HKD","LU1804176565.USD","LU0348767384.USD","LU0868486357.SGD","LU0886674414.USD","LU1951186391.HKD","09179","LU2133065610.SGD","LU0315178854.USD","LU0106959298.USD","HK0000914660.USD","IE00B031HY20.USD","LU0049112450.USD","BK1615","LU0577902611.USD","LU0572940350.SGD","LU0651947912.USD","IE00B031HW06.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1173990157","title":"同源康医药-B3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1173990157","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173990157?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:46","pubTimestamp":1775641610,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司于2026年4月8日披露截至2026年3月31日的股份变动月报表。公告显示，公司报告期内完成将4,608,000股非上市股份转换为等量H股，但已发行股份总数保持不变。其中，H股数量从上月底的375,457,818股增至380,065,818股，非上市股份则相应降至0股。截至3月31日，公司股本总数依旧为380,065,818股，股权转换未对股本规模造成影响。本次月报表由执行董事、董事长兼总裁吴豫生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102506261","title":"同源康医药-B更新3月股份变动月报表：非上市股份转换为H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1102506261","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102506261?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:37","pubTimestamp":1775119044,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司于2026年4月2日发布3月股份变动月报表，报告期截至2026年3月31日。根据公告，公司在本月内完成4,608,000股非上市股份向H股的转换。转换后，H股股本从上月底的375,457,818股增至380,065,818股，非上市股份则由4,608,000股降至0股。公司已发行股份总数维持380,065,818股不变，未出现股份回购、注销或新增发行。公司称将继续遵守香港联交所《上市规则》及相关法律法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102440781","title":"异动解读 | 同源康医药-B盘中大涨7.26%，因业绩发布及AACR年会展示创新药成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1102440781","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102440781?lang=zh_cn&edition=full","pubTime":"2026-04-01 12:53","pubTimestamp":1775019229,"startTime":"0","endTime":"0","summary":"同源康医药-B今日盘中大涨7.26%，引起了市场的广泛关注。消息面上，公司发布了截至2025年12月31日止年度的业绩，研发成本约2.44亿元，同比增加3.7%；其他收入及收益3760.9万元，同比增加23.14%，显示出公司在研发投入和财务表现上的积极进展。本届AACR年会将于2026年4月17日至22日在美国圣地亚哥举行，公司参会壁报将分别于4月19日至4月21日展示，这被视为公司研发实力和未来增长潜力的重要展示窗口，可能进一步推动投资者乐观情绪。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624156615","title":"港股异动 | 同源康医药-B(02410)涨超7% 年度研发成本约2.44亿元 将于AACR年会展示五项创新药研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2624156615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624156615?lang=zh_cn&edition=full","pubTime":"2026-04-01 11:58","pubTimestamp":1775015895,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B涨超7%，截至发稿，涨7.07%，报10.9港元，成交额3053.72万港元。消息面上，3月31日，同源康医药-B发布截至2025年12月31日止年度业绩，研发成本约2.44亿元，同比增加3.7%；其他收入及收益3760.9万元，同比增加23.14%。本届AACR年会将于2026年4月17日至22日在美国圣地亚哥举行，本公司参会壁报将分别于4月19日至4月21日展示。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1574","BK4585","02410","BK1161","BK1515","VXUS","159938","09939","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318523","title":"同源康医药-B(02410)发布年度业绩 研发成本约2.44亿元 同比增加3.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623318523?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:01","pubTimestamp":1774861277,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布截至2025年12月31日止年度业绩，研发成本约2.44亿元，同比增加3.7%;其他收入及收益3760.9万元，同比增加23.14%。于报告期间，其他收入及收益主要包括与收入相关的政府补助、与无息融资相关的政府补助以及出售一间附属公司的收益。作为一家专注于开发用于癌症治疗的小分子靶向治疗的公司，公司已建立由10款候选药物组成的管线。公司在原有组织架构基础上逐步补充商业化团队，挖掘市场潜力，不断深度挖掘产品的销售潜力并丰富品牌推广，通过参加各种学术会议、行业合作、平台合作等形式，丰富企业品牌的推广形式，提高企业品牌在行业内的知名度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","BK1515","159938","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622072086","title":"同源康医药-B(02410)将于2026年AACR年会上展示五个创新药项目的研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2622072086","media":"智通财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622072086?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:42","pubTimestamp":1774449755,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，本公司将于2026年美国癌症研究协会(AACR)年会壁报环节展示TY-0609(CDK4抑制剂)、TY-2699a(CDK7抑制剂 )、 TY-2719(EGFR/FAK(PROTAC)抑制剂)、PI3Kα(PI3Kα抑制剂)、TY-1054 (YAP-TEAD抑制剂)五个在研创新药项目的研究进展和成果，此次展示的五个项目均为本公司自主研发的抗肿瘤小分子创新候选药物。本届AACR年会将于2026 年4月17日至22日在美国圣地亚哥举行，本公司参会壁报将分别于4月19日至4月 21日展示。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","06978","159938","09939","02410","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618925456","title":"同源康医药-B03月11日主力净流出24.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618925456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618925456?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:16","pubTimestamp":1773216967,"startTime":"0","endTime":"0","summary":"03月11日, 同源康医药-B股价跌0.63%，报收11.03元，成交金额1268.9万元，换手率0.30%，振幅2.34%，量比0.32。同源康医药-B今日主力资金净流出24.9万元，上一交易日主力净流入45.9万元。该股近5个交易日上涨6.46%，主力资金累计净流入272.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出111.2万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162237a460ad55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162237a460ad55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1574","BK1161","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618646404","title":"每日卖空追踪 | 同源康医药-B 03月09日卖空量成交1.4万股，卖空比例为0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618646404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618646404?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间03月09日，涨0.81%，卖空量成交1.4万股，较上一交易日增加12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163410a45ae812&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163410a45ae812&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","02410","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617652988","title":"同源康医药-B03月06日获主力加仓207.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617652988","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617652988?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:15","pubTimestamp":1772784925,"startTime":"0","endTime":"0","summary":"03月06日, 同源康医药-B股价涨3.06%，报收11.10元，成交金额4762.6万元，换手率1.12%，振幅7.24%，量比1.19。同源康医药-B今日主力资金净流入207.5万元，上一交易日主力净流入43.9万元。该股近5个交易日下跌12.22%，主力资金累计净流出69.3万元；近20日主力资金累计净流出111.0万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161641a6aa2a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161641a6aa2a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617250977","title":"港股异动 | 同源康医药-B(02410)涨超5% 公司完成H股全流通 艾多替尼上市申请获正式受理并纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2617250977","media":"智通财经网","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617250977?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:55","pubTimestamp":1772769322,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B涨超5%，截至发稿，涨4.92%，报11.34港元，成交额2758.77万港元。消息面上，3月4日，同源康医药-B发布公告，本公司董事会欣然宣布，460.8万股非上市股份已于2026年3月4日完成转换为H股，该等经转换H股将于2026年3月5日上午九时正开始于联交所上市。近期，同源康医药-B宣布，其自主研发的针对非小细胞肺癌脑转移的甲磺酸艾多替尼片新药上市申请已获得中国国家药品监督管理局药品审评中心正式受理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02410","BK1515","09939","BK1574","VXUS","BK4585","BK4588","159938","VT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115404116","title":"同源康医药-B（02410）更新翌日披露报表，持股变动1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115404116","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115404116?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:01","pubTimestamp":1772614913,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（同源康医药-B，02410）于2026年3月4日发布公告，披露公司已发行股本变动情况。公告显示，公司将4,608,000股非上市股份转换为同等数量的H股，占转换前公司已发行H股总数的约1.23%。\n本次股份转换完成后，公司H股由375,457,818股增至380,065,818股，非上市股份则由4,608,000股降至0股。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。\n公告由执行董事、董事长兼总裁吴豫生签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142666953","title":"同源康医药-B（02410）2026年2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1142666953","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142666953?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:53","pubTimestamp":1772614417,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（同源康医药-B，02410）于2026年3月4日发布2026年2月股份变动月报表，报告期截至2026年2月28日。\n公司公告显示，截至本月底，H股发行数量维持375,457,818股，与上月底持平；非上市股份数量则维持4,608,000股，总股本维持380,065,818股。报告期内，公司并无新增发行、购回、注销或库藏股变动。\n公告同时披露，公司已符合相关公众持股量要求。期内并无股份期权或可换股票据等其他股本相关变动或交易安排。公司确认遵守香港联交所上市规则及相关法律规定。\n本次公告由执行董事、董事长兼总裁吴豫生签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0954},{"period":"1month","weight":-0.1107},{"period":"3month","weight":-0.1815},{"period":"6month","weight":-0.2882},{"period":"1year","weight":-0.5602},{"period":"ytd","weight":-0.3257}],"compareEarnings":[{"period":"1week","weight":-0.0081},{"period":"1month","weight":-0.0147},{"period":"3month","weight":-0.0144},{"period":"6month","weight":-0.0141},{"period":"1year","weight":0.0905},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发，其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI，对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂，用于治疗实体瘤。","exchange":"SEHK","name":"同源康医药-B","nameEN":"TYK MEDICINES-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同源康医药-B,02410,同源康医药-B股票,同源康医药-B股票老虎,同源康医药-B股票老虎国际,同源康医药-B行情,同源康医药-B股票行情,同源康医药-B股价,同源康医药-B股市,同源康医药-B股票价格,同源康医药-B股票交易,同源康医药-B股票购买,同源康医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}